Paper Details

  1. Home
  2. Paper Details

Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy.

Author: BlackhallFiona H, De RuysscherDirk, Faivre-FinnCorinne, KohPek Keng

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study explores the combination of targeted agents and radiotherapy in treating non-small cell lung cancer (NSCLC), highlighting the growing understanding of molecular subtypes and the need for further research on optimal treatment approaches.
Paper Details　
Original Abstract of the Article :
In recent years there has been undoubted progress in the evaluation and development of targeted agents for non-small cell lung cancer (NSCLC). A major contributor has been the discovery of molecular subtypes harbouring a critical oncogenic driver mutation, specifically sensitizing mutations in the e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ctrv.2011.11.003

データ提供：米国国立医学図書館（NLM）

Targeted Therapy and Radiotherapy: A Promising Combination for Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. This review explores the emerging role of targeted agents in NSCLC treatment, focusing on their potential benefits and the rationale for combining them with thoracic radiotherapy. The authors examine the current understanding of how these therapies interact and their potential impact on patient outcomes.

Targeted Therapy and Radiotherapy: A Synergistic Approach to NSCLC Treatment

The review highlights the potential of combining targeted agents with radiotherapy in NSCLC treatment. It suggests that this approach may offer a synergistic benefit, potentially leading to improved treatment outcomes. The authors discuss the rationale for combining these therapies, emphasizing the importance of understanding the molecular subtypes of NSCLC and tailoring treatment strategies accordingly. This review underscores the need for further research to optimize the use of targeted agents and radiotherapy in NSCLC treatment.

Improving Treatment Outcomes for Non-Small Cell Lung Cancer

This review provides valuable insights into the future of NSCLC treatment, suggesting that a combination of targeted therapy and radiotherapy could offer a more effective and personalized approach to managing this challenging disease. The review's findings emphasize the importance of ongoing research to better understand the complex interactions between these therapies and develop optimized treatment regimens. This research is a beacon of hope for patients with NSCLC, suggesting that advancements in targeted therapy and radiotherapy could lead to improved treatment outcomes and a better quality of life.

Dr.Camel's Conclusion

This review examines the potential of combining targeted therapy and radiotherapy for NSCLC treatment, like a camel caravan traversing a vast desert, seeking a path to a better future. It suggests that this approach could offer a synergistic benefit, potentially leading to improved outcomes. This research reminds us that the fight against cancer requires a multifaceted approach, with scientists and clinicians constantly innovating to find new and more effective treatment strategies.

Date :
  1. Date Completed 2012-08-15
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

22196919

DOI: Digital Object Identifier

10.1016/j.ctrv.2011.11.003

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.